Table 2 RiiQ™ Symptoms Scale internal consistency reliability in participants with RSV-positive disease status

Vaccine trial

 ARI Day 1 (PRO eDiary)

0.68, 40

0.82, 40

 ARI Day 3–5 (site visit)

0.74, 43

0.78, 41

 ARI Day 29 (site visit)

0.72, 53

0.61, 53

HARTI

 Baseline^†

0.76, 100

0.73, 100

 Prior to discharge

0.73, 54

0.79, 54

 Follow-up

0.70, 86

0.71, 86